Skip to main content

Softbank Group Corp

SEC CIK
0001065521
Latest filing
Aug 14, 2026

NMRA holding history

Neumora Therapeutics, Inc. in every 13F filed by Softbank Group Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NMRA overviewAll 13F holders of NMRAFull Q2 2026 holdings

Shares (Q2 2026)
6,090,301
Value
$10.4M
% of portfolio
0.1%
Quarters held
12
Since Q3 2023
Holdings of NMRA by Softbank Group Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,090,301$10.4M0.1%00.0%UnchangedHolders
Q1 20266,090,301$11.9M0.1%−339,419−5.3%ReducedHolders
Q4 20256,429,720$11.5M0.1%−111,470−1.7%ReducedHolders
Q3 20256,541,190$11.9M<0.1%00.0%UnchangedHolders
Q2 20256,541,190$4.80M<0.1%00.0%UnchangedHolders
Q1 20256,541,190$6.54M<0.1%00.0%UnchangedHolders
Q4 20246,541,190$69.3M0.3%−1,005,726−13.3%ReducedHolders
Q3 20247,546,916$99.7M0.5%−100,000−1.3%ReducedHolders
Q2 20247,646,916$75.2M0.4%00.0%UnchangedHolders
Q1 20247,646,916$105.1M0.6%00.0%UnchangedHolders
Q4 20237,646,916$130.4M0.7%00.0%UnchangedHolders
Q3 20237,646,916$107.9M1.2%+7,646,916NewHolders